Increased levels of soluble LR11 in cerebrospinal fluid of patients with alzheimer disease

Dementia and Geriatric Cognitive Disorders

Volumn 30, Issue 1, 2010, Pages 28-32

  Ikeuchi, Takeshi ^a   Hirayama, Satoshi ^b   Miida, Takashi ^b   Fukamachi, Isamu ^c   Tokutake, Takayoshi ^a   Ebinuma, Hiroyuki ^c   Takubo, Kohei ^c   Kaneko, Hiroyuki ^a   Kasuga, Kensaku ^a   Kakita, Akiyoshi ^a   Takahashi, Hitoshi ^a   Bujo, Hideaki ^d   Saito, Yasushi ^e   Nishizawa, Masatoyo ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c SEKISUI CHEMICAL CO LTD   (Japan)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e CHIBA UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; ApoE4; Biomarker; Lipoprotein receptor; LR11

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; LIPOPROTEIN RECEPTOR; LIPOPROTEIN RECEPTOR 11; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; TAU PROTEINS;

EID: 77955112799     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315539     Document Type: Article

References (17)

1. Miida T, Takahashi A, Ikeuchi T: Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleoitropic effects. Pharmacol Ther 2007; 113: 378-393.
2. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni A, Duara R, Friedland RP, Inzelberg R, Hampe W, Bujo H, Song YQ, Andersen OM, Willnow TE, Graff-Radford N, Petersen RC, Dickson D, Der SD, Fraser PE, Schmitt-Ulms G, Younkin S, Mayeux R, Farrer LA, St George-Hyslop P: The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39: 168-177.
3. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, von Arnim CA, Breiderhoff T, Jansen P, Wu X, Bales KR, Cappai R, Masters CL, Gliemann J, Mufson EJ, Hyman BT, Paul SM, Nykjaer A, Willnow TE: Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 2005; 102: 13461-13466.
4. Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI, Lah JJ: The lipoprotein receptor LR11 regulates amyloid β production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 2006; 26: 1596-1603.
5. Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ, Schaller C, Bujo H, Levey AI, Lah JJ: Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol 2004; 61: 1200-1205.
6. Sager KL, Wuu J, Leurgans SE, Rees HD, Gearing M, Mufson EJ, Levey AI, Lah JJ: Neuronal LR11/SorLA expression is reduced in mild cognitive impairment. Ann Neurol 2007; 62: 640-647.
7. Matsuo M, Ebinuma H, Fukamachi I, Jiang M, Bujo H, Saito Y: Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis. Clin Chem 2009; 55: 1801-1808.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
9. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1999; 51: 1546-1554.
10. Kasuga K, Shimohata T, Nishimura A, Shiga A, Mizuguchi T, Tokunaga J, Ohno T, Miyashita A, Kuwano R, Matsumoto N, Onodera O, Nishizawa M, Ikeuchi T: Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease. J Neurol Neurosurg Psychiatry 2009; 80: 1050-1052.
11. Taira K, Bujo H, Hirayama S, Yamazaki H, Kanaki T, Takahashi K, Ishii I, Miida T, Schneider WJ, Saito Y: LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol 2001; 21: 1501-1506.
12. Miida T, Yamada T, Seino U, Ito M, Fueki Y, Takahashi A, Kosuge K, Soda S, Hanyu O, Obayashi K, Miyazaki O, Okada M: Serum amyloid A (SAA)-induced remodeling of CSF-HDL. Biochim Biophys Acta 2006; 1761: 424-433.
13. Hampe W, Riedel IB, Lintzel J, Bader CO, Franke I, Schaller HC: Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator. J Cell Sci 2000; 113: 4475-4485.
14. Zhu Y, Bujo H, Yamazaki H, Ohwaki K, Jiang M, Hirayama S, Kanaki T, Shibasaki M, Takahashi K, Schneider WJ, Saito Y: LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration. Circ Res 2004; 94: 721-758.
15. Jiang M, Bujo H, Ohwaki K, Unoki H, Yamazaki H, Kanaki T, Shibasaki M, Azuma K, Harigaya K, Schneider WJ, Saito Y: Ang II-stimulated migration of vascular SMC is dependent on LR11. J Clin Invest 2008; 118: 2733-2746.
16. Ma QL, Galasko DR, Ringman JM, Vinters HV, Edland SD, Pomakian J, Ubeda OJ, Rosario ER, Teter B, Frautschy SA, Cole GM: Reduction of SorLA/LR11, a sorting protein limiting β-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol 2009; 66: 448-457.
17. Ma QL, Teter B, Ubeda OJ, Morihara T, Dhoot D, Nyby MD, Tuck ML, Frautschy SA, Cole GM: Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci 2007; 27: 14299-14307.